Juliane Hoffmann
Overview
Explore the profile of Juliane Hoffmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
401
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pawlitzki M, Uebelhor J, Sweeney-Reed C, Stephanik H, Hoffmann J, Lux A, et al.
Nutrients
. 2018 Jul;
10(8).
PMID: 30049983
Objective: Diminished blood levels of zinc have been reported to be associated with T-cell-mediated autoimmunity, which has been implicated in multiple sclerosis (MS). We aimed to compare the distribution of...
2.
Colic L, Woelfer M, colic M, Leutritz A, Liebe T, Fensky L, et al.
Eur Neuropsychopharmacol
. 2018 Apr;
28(6):701-709.
PMID: 29699723
Recently, ketamine has been investigated as a potential antidepressant option for treatment resistant depression. Unlike traditional drugs, it yields immediate effects, most likely via increased glutamatergic transmission and synaptic plasticity....
3.
Kohli S, Hoffmann J, Lochmann F, Markmeyer P, Huebner H, Fahlbusch F, et al.
Cell Death Dis
. 2017 Apr;
8(4):e2730.
PMID: 28383551
Placental insufficiency jeopardizes prenatal development, potentially leading to intrauterine growth restriction (IUGR) and stillbirth. Surviving fetuses are at an increased risk for chronic diseases later in life. IUGR is closely...
4.
Kohli S, Ranjan S, Hoffmann J, Kashif M, Daniel E, Al-Dabet M, et al.
Blood
. 2016 Sep;
128(17):2153-2164.
PMID: 27589872
Preeclampsia (PE) is a placenta-induced inflammatory disease associated with maternal and fetal morbidity and mortality. The mechanisms underlying PE remain enigmatic and delivery of the placenta is the only known...
5.
Lingohr P, Dohmen J, Matthaei H, Konieczny N, Hoffmann J, Bolke E, et al.
Eur J Med Res
. 2016 Feb;
21:4.
PMID: 26846568
Background: Laparoscopic Surgery has become a worldwide standard procedure for a variety of indications. This has been attributed to a milder postoperative inflammatory response by the innate immune system potentially...
6.
Wittenbecher C, di Giuseppe R, Biemann R, Menzel J, Arregui M, Hoffmann J, et al.
PLoS One
. 2015 Sep;
10(9):e0138480.
PMID: 26402656
The reliability of single time point measurements of the novel adipokines retinol-binding protein 4 and omentin-1 in the blood has not been evaluated in large samples yet. The present study...
7.
Dong W, Wang H, Shahzad K, Bock F, Al-Dabet M, Ranjan S, et al.
J Am Soc Nephrol
. 2015 May;
26(11):2789-99.
PMID: 26015455
Ischemia-reperfusion injury (IRI) is the leading cause of ARF. A pathophysiologic role of the coagulation system in renal IRI has been established, but the functional relevance of thrombomodulin (TM)-dependent activated...
8.
Haase-Fielitz A, Plass M, Kuppe H, Hetzer R, Ostland V, Westphal S, et al.
J Thorac Cardiovasc Surg
. 2012 Oct;
145(5):1380-6.
PMID: 23062413
Objective: Hepcidin regulates iron absorption and recycling and is central to host defense, protection from reactive iron species, and a biomarker of iron-related pathophysiology. We assessed the value of hepcidin...
9.
Csepregi A, Ebert M, Rocken C, Schneider-Stock R, Hoffmann J, Schulz H, et al.
BMC Cancer
. 2010 Jun;
10:317.
PMID: 20569442
Background: The product of CDKN2A, p16 is an essential regulator of the cell cycle controlling the entry into the S-phase. Herein, we evaluated CDKN2A promoter methylation and p16 protein expression...
10.
Csepregi A, Rocken C, Hoffmann J, Gu P, Saliger S, Muller O, et al.
J Cancer Res Clin Oncol
. 2007 Nov;
134(5):579-89.
PMID: 17973119
Purpose: We investigated the impact of promoter methylation on APC protein expression in patients with hepatocellular carcinoma (HCC). Materials And Methods: 50 patients [HCC (n=19), liver metastasis (n=19), cholangiocellular cancer...